

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb10354</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>The Effect of &lt;i&gt;TAX-1&lt;/i&gt; Gene of Human T-cell Leukemia Virus Type -1 on the Expression of CCR5 in K562 Cell Line</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Haghnazari Sadaghiani</surname><given-names>Nasrin</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Pirayeshfard</surname><given-names>Lila</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Aghaie</surname><given-names>Afsaneh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Sharifi</surname><given-names>Zohreh</given-names></name></contrib><aff>Department of Pharmaceutical Biotechnology, Faculty of Pharmacy and Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>11</volume>
      <issue>1</issue>
      <fpage>67</fpage>
      <lpage>71</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>11</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>8</day>
          <month>1</month>
          <year>2018</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: Tax-1 protein of Human T-cell Leukemia Virus type 1(HTLV-1) serves as a key transcriptional regulatory gene product and has a crucial role in transactivating genes of infected cells by employing their transcriptional factors. This modulation includes induction of genes which encode CC-chemokines and their receptors. In this study, a recombinant vector containing Tax-1 gene was made and tested for its ability to induce CCR5 (CC chemokine receptor 5) expression in K562 cell line.&lt;br /&gt;
Methods: In order to perform this research, two blood samples of HTLV-1 positive were obtained from Urmia blood transfusion center. After DNA extraction, a complete sequence of &lt;em&gt;Tax-1&lt;/em&gt; gene was amplified by specific primers. Recombinant vectors carrying Tax-1 gene were synthesized and transformed into &lt;em&gt;Escherichia coli (E. coli)&lt;/em&gt;. After bacteria transformation, bacteria containing recombinant plasmid were selected and purified. Then, the recombinant shuttle vectors, &lt;em&gt;pCDNA3.1-TAX&lt;/em&gt;, were transfected into the cell culture (K562 cell line). Expression of &lt;em&gt;CCR5&lt;/em&gt; was measured after 72 &lt;em&gt;hr&lt;/em&gt; by Syber Green Real-Time PCR method compared to control cell culture. Normalization was done with GAPDH as a standard gene.&lt;br /&gt;
Results: Cloning of &lt;em&gt;Tax-1&lt;/em&gt; gene in the vector, &lt;em&gt;pCDNA3&lt;/em&gt;.1 was confirmed by colony PCR, restriction digestion, and sequencing methods. Expression of &lt;em&gt;Tax-1&lt;/em&gt; and &lt;em&gt;CCR5&lt;/em&gt; genes were confirmed by real time PCR and also, expression of &lt;em&gt;CCR5&lt;/em&gt; gene showed an 8-fold increase in comparison to mock-treated controls (p&amp;lt;0.05).&lt;br /&gt;
Conclusion: Our data suggested that recombinant &lt;em&gt;Tax-1&lt;/em&gt; may have the enhancing effect on CCR5 expression rate at mRNA levels in K562 cell line. Further studies are necessary to evaluate the effect of&lt;em&gt; pCDNA3.1-TAX&lt;/em&gt; on cell surface CCR5 expression.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
